AbbVie has managed its patent-cliff concerns better. Pfizer has a higher-yielding dividend, but it may not be safe. AbbVie ...

Net interest margin trajectory was explicitly guided upward, with the CFO stating, "we'll get 3 to 5 basis points of margin ...

If the conflict continues, this will likely impact investor portfolios going forward. Since the war started, oil prices have ...

Much of the spending will go to missile defense, and Redwire is a key player here. As the company just announced, it has just ...

A major Diebold Nixdorf shareholder reported selling 112,305 shares on April 15 and April 16, 2026, for approximately $9.55 ...

Operational Strategy -- Management introduced a "family full life-cycle" model, integrating education, goods, and tourism ...

Larson stated, "We expect revenue to be lower as improvements in ADTech and SSR will only partially offset the reduction in ...

Don't get surprised by how work will affect your Social Security checks. If you've looked into the rules for working while ...

MBX Biosciences targets endocrine and metabolic disorders with novel peptide therapies, advancing candidates across several ...

Special mention loans increased to $455 million from $310 million due to six downgraded relationships totaling $145 million, ...

The average earnings growth of Nasdaq-100 companies exceeded that of the S&P 500 in 2025. That trend is likely to continue in 2026, driven by the growing adoption of AI hardware and software.

This ETF tracks a diversified ladder of U.S. Treasury securities, offering transparent, equal-weighted exposure across the ...